• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于修复心血管组织的环境响应水凝胶。

Environmentally responsive hydrogels for repair of cardiovascular tissue.

作者信息

Guan Shuaimeng, Li Jiankang, Zhang Kun, Li Jingan

机构信息

School of Life Science, Zhengzhou University, Zhengzhou, 450000, People's Republic of China.

School of Materials Science and Engineering, Zhengzhou University, Zhengzhou, 450000, People's Republic of China.

出版信息

Heart Fail Rev. 2021 Sep;26(5):1273-1285. doi: 10.1007/s10741-020-09934-y.

DOI:10.1007/s10741-020-09934-y
PMID:32076909
Abstract

Cardiovascular diseases (CVDs) pose a serious threat to human health, which are characterized by high disability and mortality rate globally such as myocardial infarction (MI), atherosclerosis, and heart failure. Although stem cells transplantation and growth factors therapy are promising, their low survival rate and loss at the site of injury are major obstacles to this therapy. Recently, the development of hydrogel scaffold materials provides a new way to solve this problem, which have shown the potential to treat CVD. Among these scaffold materials, environmentally responsive hydrogels have great prospects in repairing the microenvironment of cardiovascular tissues and vascular regeneration. They provide a new method for the treatment of cardiovascular tissue repair and space-time control for the release of various therapeutic drugs, including small-molecule drugs, growth factors, and stem cells. Herein, this article reviews the occurrence and current treatment of CVD, as well as the repair of cardiovascular injury by several environmental responsive hydrogels systems currently used, mainly focusing on the delivery of growth factors or the application of cell therapy to revascularization. In addition, we will also discuss the enormous potential and personal perspectives of environmentally responsive hydrogels in cardiovascular repair.

摘要

心血管疾病(CVDs)对人类健康构成严重威胁,其在全球范围内具有高致残率和高死亡率的特点,如心肌梗死(MI)、动脉粥样硬化和心力衰竭。尽管干细胞移植和生长因子疗法前景广阔,但其低存活率以及在损伤部位的流失是该疗法的主要障碍。最近,水凝胶支架材料的发展为解决这一问题提供了新途径,已显示出治疗心血管疾病的潜力。在这些支架材料中,环境响应性水凝胶在修复心血管组织微环境和血管再生方面具有巨大前景。它们为心血管组织修复治疗以及各种治疗药物(包括小分子药物、生长因子和干细胞)的时空控制释放提供了新方法。在此,本文综述了心血管疾病的发生及当前治疗方法,以及目前使用的几种环境响应性水凝胶系统对心血管损伤的修复作用,主要聚焦于生长因子的递送或细胞疗法在血管再生中的应用。此外,我们还将讨论环境响应性水凝胶在心血管修复中的巨大潜力和个人观点。

相似文献

1
Environmentally responsive hydrogels for repair of cardiovascular tissue.用于修复心血管组织的环境响应水凝胶。
Heart Fail Rev. 2021 Sep;26(5):1273-1285. doi: 10.1007/s10741-020-09934-y.
2
Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies.功能化水凝胶在心肌梗死治疗和药物输送策略中的进展。
ACS Appl Mater Interfaces. 2024 Sep 18;16(37):48880-48894. doi: 10.1021/acsami.4c09623. Epub 2024 Sep 3.
3
Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties.通过具有抗细胞凋亡、抗炎和促血管生成特性的心肌梗死后反应性可注射水凝胶来再生梗死心脏。
Biomaterials. 2022 Nov;290:121849. doi: 10.1016/j.biomaterials.2022.121849. Epub 2022 Oct 5.
4
Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair.干细胞与可注射水凝胶:心肌修复中的协同治疗策略。
Biotechnol Adv. 2016 Jul-Aug;34(4):362-379. doi: 10.1016/j.biotechadv.2016.03.003. Epub 2016 Mar 11.
5
Hydrogels for therapeutic cardiovascular angiogenesis.用于治疗性心血管血管生成的水凝胶。
Adv Drug Deliv Rev. 2016 Jan 15;96:31-9. doi: 10.1016/j.addr.2015.07.003. Epub 2015 Jul 23.
6
Cell or cell derivative-laden hydrogels for myocardial infarction therapy: from the perspective of cell types.细胞或细胞衍生物负载水凝胶治疗心肌梗死:从细胞类型的角度。
J Mater Chem B. 2023 Oct 25;11(41):9867-9888. doi: 10.1039/d3tb01411h.
7
Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction.基于水凝胶的心脏修复与再生功能在心肌梗死治疗中的应用
Mater Today Bio. 2024 Feb 13;25:100978. doi: 10.1016/j.mtbio.2024.100978. eCollection 2024 Apr.
8
Hydrogels for the Treatment of Myocardial Infarction: Design and Therapeutic Strategies.用于治疗心肌梗死的水凝胶:设计与治疗策略
Macromol Biosci. 2024 Feb;24(2):e2300302. doi: 10.1002/mabi.202300302. Epub 2023 Oct 17.
9
Overview of hydrogel-based strategies for application in cardiac tissue regeneration.用于心脏组织再生的水凝胶基策略概述。
Biomed Mater. 2015 Jun 4;10(3):034005. doi: 10.1088/1748-6041/10/3/034005.
10
Biotherapeutic-loaded injectable hydrogels as a synergistic strategy to support myocardial repair after myocardial infarction.载生物治疗剂的可注射水凝胶作为心肌梗死后支持心肌修复的协同策略。
J Control Release. 2021 Jul 10;335:216-236. doi: 10.1016/j.jconrel.2021.05.023. Epub 2021 May 20.

引用本文的文献

1
Soft, Deformable Polyurethane-Boronic Acid Nanoparticles as Dynamic Cross-Linkers to Construct 3D-Bioprintable Hydrogels.柔软、可变形的聚氨酯-硼酸纳米颗粒作为动态交联剂用于构建3D生物可打印水凝胶。
ACS Appl Mater Interfaces. 2025 Jul 30;17(30):43565-43583. doi: 10.1021/acsami.5c07208. Epub 2025 Jul 8.
2
Stem Cell Therapy in Ischemic Heart Failure.缺血性心力衰竭的干细胞治疗
Am J Cardiovasc Drugs. 2025 Jun 27. doi: 10.1007/s40256-025-00741-0.
3
Design Strategies and Application Potential of Multifunctional Hydrogels for Promoting Angiogenesis.

本文引用的文献

1
Strategies to improve the response rate of thermosensitive hydrogels.提高热敏水凝胶响应率的策略。
Soft Matter. 2008 Feb 21;4(3):385-391. doi: 10.1039/b713803m.
2
Potential application of an injectable hydrogel scaffold loaded with mesenchymal stem cells for treating traumatic brain injury.负载间充质干细胞的可注射水凝胶支架在治疗创伤性脑损伤中的潜在应用。
J Mater Chem B. 2018 May 21;6(19):2982-2992. doi: 10.1039/c7tb03213g. Epub 2018 Apr 25.
3
Statins for primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
用于促进血管生成的多功能水凝胶的设计策略及应用潜力
Int J Nanomedicine. 2024 Nov 27;19:12719-12742. doi: 10.2147/IJN.S495971. eCollection 2024.
4
Advances in the Research and Application of Smart-Responsive Hydrogels in Disease Treatment.智能响应水凝胶在疾病治疗中的研究与应用进展
Gels. 2023 Aug 17;9(8):662. doi: 10.3390/gels9080662.
5
Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac tissue engineering.刺激响应性水凝胶:用于心脏组织工程的智能先进平台。
Front Bioeng Biotechnol. 2023 Jun 28;11:1174075. doi: 10.3389/fbioe.2023.1174075. eCollection 2023.
6
A Critical Review on Classified Excipient Sodium-Alginate-Based Hydrogels: Modification, Characterization, and Application in Soft Tissue Engineering.基于海藻酸钠的分级辅料水凝胶的批判性综述:改性、表征及其在软组织工程中的应用
Gels. 2023 May 22;9(5):430. doi: 10.3390/gels9050430.
7
Research Advances of Injectable Functional Hydrogel Materials in the Treatment of Myocardial Infarction.可注射功能性水凝胶材料治疗心肌梗死的研究进展
Gels. 2022 Jul 6;8(7):423. doi: 10.3390/gels8070423.
8
Bioresponsive drug delivery systems for the treatment of inflammatory diseases.用于治疗炎症性疾病的生物响应性药物输送系统。
J Control Release. 2020 Nov 10;327:641-666. doi: 10.1016/j.jconrel.2020.09.008. Epub 2020 Sep 8.
BMJ. 2019 Oct 16;367:l5674. doi: 10.1136/bmj.l5674.
4
Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.重新审视阿司匹林在心血管疾病一级预防中的作用。
Circulation. 2019 Sep 24;140(13):1115-1124. doi: 10.1161/CIRCULATIONAHA.119.040205. Epub 2019 Sep 23.
5
Hierarchically designed bone scaffolds: From internal cues to external stimuli.分层设计的骨支架:从内部线索到外部刺激。
Biomaterials. 2019 Oct;218:119334. doi: 10.1016/j.biomaterials.2019.119334. Epub 2019 Jul 3.
6
RNA-based diagnostic and therapeutic strategies for cardiovascular disease.基于 RNA 的心血管疾病诊断和治疗策略。
Nat Rev Cardiol. 2019 Nov;16(11):661-674. doi: 10.1038/s41569-019-0218-x. Epub 2019 Jun 11.
7
Lymphatic system identification, pathophysiology and therapy in the cardiovascular diseases.淋巴系统在心血管疾病中的鉴定、病理生理学和治疗。
J Mol Cell Cardiol. 2019 Aug;133:99-111. doi: 10.1016/j.yjmcc.2019.06.002. Epub 2019 Jun 7.
8
Hot topics and trends in cardiovascular research.心血管研究的热点和趋势。
Eur Heart J. 2019 Jul 21;40(28):2363-2374. doi: 10.1093/eurheartj/ehz282.
9
An injectable scaffold based on temperature-responsive hydrogel and factor-loaded nanoparticles for application in vascularization in tissue engineering.一种基于温敏水凝胶和因子负载纳米颗粒的可注射支架,用于组织工程中的血管化应用。
J Biomed Mater Res A. 2019 Oct;107(10):2123-2134. doi: 10.1002/jbm.a.36723. Epub 2019 May 24.
10
Informed Shared Decisions for Patients with Aortic Stenosis.主动脉瓣狭窄患者的知情共同决策
N Engl J Med. 2019 May 2;380(18):1769-1770. doi: 10.1056/NEJMe1903316.